0001104659-24-010131.txt : 20240202 0001104659-24-010131.hdr.sgml : 20240202 20240202170148 ACCESSION NUMBER: 0001104659-24-010131 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240202 DATE AS OF CHANGE: 20240202 EFFECTIVENESS DATE: 20240202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: EnteroBiotix LTD CENTRAL INDEX KEY: 0001946072 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-504320 FILM NUMBER: 24592515 BUSINESS ADDRESS: STREET 1: PHOENIX HOUSE STREET 2: STRATHCLYDE BUSINESS PARK CITY: BELLSHILL STATE: X0 ZIP: ML4 3NJ BUSINESS PHONE: 00441698501370 MAIL ADDRESS: STREET 1: 1 WEST REGENT STREET CITY: GLASGOW STATE: X0 ZIP: G2 1AP D 1 primary_doc.xml X0708 D LIVE 0001946072 EnteroBiotix LTD PHOENIX HOUSE STRATHCLYDE BUSINESS PARK GLASGOW X0 UNITED KINGDOM ML4 3NJ 00441698501370 UNITED KINGDOM None None Other Private Limited Company Registered in Scotland, UK true Iain Baird 1 West Regent Street Glasgow X0 UNITED KINGDOM G2 1AP Director Christopher Lea 1 West Regent Street Glasgow X0 UNITED KINGDOM G2 1AP Executive Officer Chief Financial Officer and Company Secretary Mark Bamforth 1 West Regent Street Glasgow X0 UNITED KINGDOM G2 1AP Director Promoter David Lawrence 1 West Regent Street Glasgow X0 UNITED KINGDOM G2 1AP Director James McIlroy Aberdeen & North East Blood Transfusion Centre, Foresterhill Road Aberdeen X0 UNITED KINGDOM AB25 2ZW Executive Officer Director Chief Executive Officer Elmar Schnee 1 West Regent Street Glasgow X0 UNITED KINGDOM G2 1AP Director Douglas Thomson 1 West Regent Street Glasgow X0 UNITED KINGDOM G2 1AP Director Biotechnology Decline to Disclose 06b false 2024-01-19 false true false 31827 Indefinite 2565225 Indefinite Issue is denominated in GBP to the nearest $1. All amounts have been converted from GBP to USD at the rate of (pound)1GBP to $1.2733 USD (January 31, 2024) false 3 0 0 0 false EnteroBiotix LTD /s/ James R. McIlroy James R. McIlroy Chief Executive Officer 2024-02-02